Pyrogen Testing Market Observes Significant Growth with CAGR of 12.4% during the Forecast period 2020-2027
![]() |
Pyrogen Testing Market |
Pyrogen Testing is important in
modern healthcare since it identifies the presence of pyrogen in an organism
that produces fever. Lipopolysaccharides and lepoteichoic acid include pyrogen.
Contaminated pyrogenic compounds can affect the human body by causing fever.
Pyrogen testing is used to determine the presence of pyrogens in pharmaceutical
dosage forms and medical devices. Pyrogen-contaminated injections can induce
temperature dysregulation (fever), bodily aches, inflammation, shock,
multiorgan failure, and other life-threatening complications after delivery.
The rising frequency of major
infectious illnesses and epidemics has resulted in a continuous increase in
demand for pyrogen testing procedures over the last decade. The demand for
pyrogen testing techniques (used for endotoxin and microbiological
identification) is predicted to rise throughout the forecast period due to an increase
in the occurrence of infectious illnesses worldwide. Endotoxin detection
products can help with infectious illness management, especially in places with
little healthcare infrastructure.
The global Pyrogen
Testing Market is estimated to be valued at US$ 979.7 million in
2020 and is expected to exhibit a CAGR of 12.4% over the forecast period
(2020-2027).
APAC countries are very
profitable markets for the life sciences sector. For example, India has taken
great steps to promote itself as the world's leading major biopharmaceutical
innovation hub, including fostering public-private partnerships (PPPs) in
biopharmaceutical R&D projects. South Korea is likewise working to
establish itself as a worldwide biotech centre, with an emphasis on
biosimilars, vaccine manufacturing, and stem cell treatments. The increasing
need for curative medicines for life-threatening diseases such as cancer and
diabetes underscores the importance of drug R&D and, as a result, the
demand for pyrogen testing kits for effective quality testing and management.
The market for pyrogen testing is
extremely concentrated. In 2019, the main companies in the pyrogen testing
market were Charles River Laboratories, Inc. (US), Lonza (Switzerland), Merck
KGaA (Germany), Thermo Fisher Scientific, Inc. (US), and Associates of Cape
Cod, Inc. (US). There is fierce rivalry among market participants. Only large
corporations can afford large capital investments as well as hefty R&D and
manufacturing costs. Furthermore, future entrants will be discouraged from
entering this industry. Furthermore, the market's top companies are substantial
and well-established, with strong brand loyalty.
Various Pryogen Testing Types-
1. LAL
Tests
·
Chromogenic Tests
·
Turbidimetric Tests
2. Gel
Clot Tests
3. In
Vitro Tests
4. Rabbit
Tests
Major players operating in the global pyrogen testing market include
Thermo Fisher Scientific, Merck KGaA, Lonza Group, Associates of Cape Cod Inc.,
Charles River Laboratories Inc., GenScript, WuXi PharmaTech (Cayman), Inc.,
bioMérieux, Wako Chemicals USA, Inc., Sanquin,
Ellab A/S, and Pyrostar.
Comments
Post a Comment